Connect AfyaTransforming Diagnostics and Research in
Africa through Operational ExcellenceWe are seeing two level of Access Issues in Africa..
To Africa

From Africa

Access to diagnostics
at local level

Access to treatment
and research at global

Lack of diagnostic andresearch infrastructures

20% vs. 2%
1.5 Billion•Despite huge
population (20%) andits genetic diversity,
the world cannot
have access to suchpatient data•

African genetic datais only 2% of
globally available
genetic data•

This will cause thedelay of the newdiagnostics,
treatment andvaccination at theglobal level

Patients

ResearchersLabs•

20% of world’s population resides
in Africa in 2020•

By 2050, the number will be 25%

Globalcompanies

Infectious
DiseaseCancerDiabetes

2' -Connect Afya is “Connecting” these two aspects of issues by
having unique one-stop shop solutions
Enable Access toDiagnostics at local level

Partnerships with Global
Organizations•1 Deployment ofadvanced clinicallaboratories, including
clinic sequencing, in
Kenya and East Africa•2 Research and clinical
trial support incollaboration with
globalhealthcare/pharmaceu
tical companies

The only one-stop shop to improve the access to the diagnostics
and research in East Africa

Clinical & Research labthat covers from routine
to gene sequencing

Digitalized clinic chain for thebest patient experience

Distributorship for molecular
reagents that can control thecosts and supply
3' -Connect Afya is gearing up our business and operations
STEP1:
Pursuing In-house
operational excellence

STEP3:
Realize the partnershipvalue at global level

STEP2:
Control operations
including external
medical instirutions• The only unique platform• Manage the clinical• Established operational
excellence to manage
samples and control logistics■ Acquired assets• Handled 60,000+ samples• Collaboration with
50+ partners leveraging
our networks/know how

Diagnostics LabResearch/Trialsamples•

for diagnostics andclinical research
The essential partner for
any clinical research/trial
in East Africa and beyond■Assets to be acquired• Operational controls forexternal labs/clinics• One stop secured storage
service for confidential ate
such as genetic data andpersonal data (e.g.,anonymisation)■Assets to be acquired• Operations with global
pharma/diagnostics
companies by leveraging
diagnostics platform• Collaborations withinternational foundationsandClinical ResearchLab/SMO

True one-stop shopfor diagnostics/Research4' -We are working on Open Genomic innovation Hub in East Africa
What we are aiming forInitiatives• Collecting ~10 patients in each tribeof Kenya for Whole Genome
Sequencing• The sequenced data will be “OpenData” that can be used for referenceof any research and development ofnew diagnostic tests and research.

FlagshipOpen
Genome
DataProject• Currently constructing one of thebiggest clinical & research lab in EastAfrican at the center of Nairobi• The new lab has a co-working spaceand make gene sequencer available
for local researchers calling it “OpenInnovation Hub”•

We are creating “synergy” bystarting new initiatives on top ofdiagnostics lab operationOpenInnovationHubOne stop
Diagnostics
LabKPIs in 2 years+5+10+1# of Local and globalorganizations partneredwith this Innovation Hub# of research
publications enabledthrough the Open
Sequenced Data

# of diagnostic products
from the Open
Sequenced Data

+120,000# of samples in ourdiagnostic lab

5' -We are looking for Equity and Grant partners
Equity Finance▪ We are seeking for 1 M -1.5 M USD in early-stage financing for ourfurther growth in Q4 2023
– 550K USD has been committed through Grant Program from Japanese company andJapanese Government program – Total funding will be 1.5M-2M USD▪ With this financing, we would like to conquer Kenyan specialized test
market and start collaboration with global organizations
Grant Program▪ We are seeking for Research Grant Partner to enable our Open Genome
Data Project▪ The expected starting time will be in Q2-Q3 in 2024

Please talk to Yoichi in the conference or contactyoichi.Shimada@connectafya.com
6' -